ABEONA THERAPEUTICS INC. Preferred Stock Dividends, Income Statement Impact
ABEONA THERAPEUTICS INC. (ABEO) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2016-03-30
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2014 was $2.88M, a 0.79% decline from fiscal 2013.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2013 was $2.90M, a 44.97% increase from fiscal 2012.
- ABEONA THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2012 was $2.00M, a 12.68% increase from fiscal 2011.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month | Preferred Stock Dividends, Income Statement Impact 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | $684.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | $684.00K derived: sum of 3 quarters · filed 2016-03-30 | $1.42M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | $684.00K derived: sum of 2 quarters · filed 2016-03-30 | $1.42M derived: sum of 3 quarters · filed 2016-03-30 | $2.15M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.42M derived: sum of 2 quarters · filed 2016-03-30 | $2.15M derived: sum of 3 quarters · filed 2016-03-30 | $2.88M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $740.00K 10-Q · filed 2015-11-16 | $1.47M derived: sum of 2 quarters · filed 2015-11-16 | $2.19M 10-Q · filed 2015-11-16 | $2.89M derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | $726.00K 10-Q · filed 2015-08-14 | $1.45M 10-Q · filed 2015-08-14 | $2.15M derived: sum of 3 quarters · filed 2015-08-14 | $2.89M derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $725.00K 10-Q · filed 2015-05-14 | $1.42M derived: sum of 2 quarters · filed 2015-05-14 | $2.16M derived: sum of 3 quarters · filed 2015-05-14 | $2.90M derived: sum of 4 quarters · filed 2015-05-14 | |
| 2013-12-31 | $696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $1.44M derived: sum of 2 quarters · filed 2015-03-31 | $2.17M derived: sum of 3 quarters · filed 2015-03-31 | $2.90M 10-K · filed 2015-03-31 | |
| 2013-09-30 | $742.00K 10-Q · filed 2014-11-14 | $1.48M derived: sum of 2 quarters · filed 2014-11-14 | $2.20M 10-Q · filed 2014-11-14 | $2.88M derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | $733.00K 10-Q · filed 2014-08-14 | $1.46M 10-Q · filed 2014-08-14 | $2.14M derived: sum of 3 quarters · filed 2014-08-14 | $2.58M derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $727.00K 10-Q · filed 2014-05-12 | $1.40M derived: sum of 2 quarters · filed 2014-05-12 | $1.85M derived: sum of 3 quarters · filed 2014-05-12 | $2.29M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $1.12M derived: sum of 2 quarters · filed 2014-03-26 | $1.56M derived: sum of 3 quarters · filed 2014-03-26 | $2.00M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $444.00K 10-Q · filed 2013-11-14 | $883.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.32M 10-Q · filed 2013-11-14 | $1.77M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $439.00K 10-Q · filed 2013-08-14 | $879.00K 10-Q · filed 2013-08-14 | $1.33M derived: sum of 3 quarters · filed 2013-08-14 | $1.77M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $440.00K 10-Q · filed 2013-05-15 | $887.00K derived: sum of 2 quarters · filed 2013-05-15 | $1.33M derived: sum of 3 quarters · filed 2013-05-15 | $1.78M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $894.00K derived: sum of 2 quarters · filed 2013-03-20 | $1.34M derived: sum of 3 quarters · filed 2013-03-20 | $1.77M 10-K · filed 2013-03-20 | -$1.77M 10-K · filed 2012-03-23 |
| 2011-09-30 | $447.00K 10-Q · filed 2012-11-14 | $889.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.33M 10-Q · filed 2012-11-14 | -$1.80M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $442.00K 10-Q · filed 2011-08-15 | $880.00K 10-Q · filed 2012-08-14 | -$2.25M derived: sum of 3 quarters · filed 2012-08-14 | -$1.80M derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $438.00K 10-Q · filed 2012-05-15 | -$2.69M derived: sum of 2 quarters · filed 2012-05-15 | -$2.24M derived: sum of 3 quarters · filed 2012-05-15 | -$1.79M derived: sum of 4 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | -$2.68M derived: sum of 2 quarters · filed 2012-03-23 | -$2.23M derived: sum of 3 quarters · filed 2012-03-23 | -$1.79M 10-K · filed 2012-03-23 | |
| 2010-09-30 | $452.00K 10-Q · filed 2011-11-14 | $898.00K derived: sum of 2 quarters · filed 2011-11-14 | $1.34M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $446.00K 10-Q · filed 2011-08-15 | $888.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |